Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-10 Patel Ronil A. Chief Business Officer Shares withheld for taxes −1,282 $3.27 $4K 90,714
2023-12-01 Patel Ronil A. Chief Business Officer Grant or award +49,692 91,996
2023-12-01 Patel Ronil A. Chief Business Officer Grant or award · Employee Stock Option (right to buy) +74,538 74,538
2023-04-24 Patel Ronil A. SVP, Operations & Bus. Dev. Grant or award +20,000 42,304
2023-04-24 Patel Ronil A. SVP, Operations & Bus. Dev. Grant or award · Employee Stock Option (right to buy) +30,000 30,000

Page 1 of 1 · 5 trades